Vimarsana
Biggest News Aggregation in the World

Disease Duration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Disease Duration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Disease Duration Today - Breaking & Trending Today

Altered CBF is linked to disease duration in GTCS patients - Vimarsana News

Altered CBF is linked to disease duration in GTCS patients

Investigating the cerebral blood flow characteristics in individuals with generalized tonic-clonic seizures (GTCS) during the interictal phase using voxel-based

Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic - Vimarsana News

Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic

Adiponectin and Leptin as Biomarkers of Disease Activity and Metabolic Disorders in Rheumatoid Arthritis Patients

Studies from Tel Aviv University Update Current Data on Parkinson's Disease (Real World Pharmacological First Treatment Patterns of Patients With Parkinson Disease and Disease Duration: a Large-scale Cohort Study Using an Health Maintenance ...): Neurodegenerative Diseases and Conditions - Parkinson's Disease - Vimarsana News

Studies from Tel Aviv University Update Current Data on Parkinson's Disease (Real World Pharmacological First Treatment Patterns of Patients With Parkinson Disease and Disease Duration: a Large-scale Cohort Study Using an Health Maintenance ...): Neurodegenerative Diseases and Conditions - Parkinson's Disease

2021 NOV 03-- By a News Reporter-Staff News Editor at Insurance Daily News-- Investigators publish new report on Neurodegenerative Diseases and Conditions- Parkinson’ s Disease. Funders for this research include National Institutes of Health- USA, European Commission, Howard Hughes Medical Institute. The news reporters obtained a quote from the research from...

Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases - Vimarsana News

Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic Diseases

Research to be presented on Orencia, deucravacitinib and pipeline assets highlights breadth of data and focus on transforming treatment paradigms for people living with rheumatic diseases Bristol Myers Squibb today announced data from 29 company-sponsored presentations across Orencia, deucravacitinib and pipeline assets will be presented at the American College of Rheumatology Convergence 2021, taking place ...

Rückenleiden wieder Nummer Eins : 22.08.2021, 08.34 Uhr - Vimarsana News

Rückenleiden wieder Nummer Eins : 22.08.2021, 08.34 Uhr

22.08.2021, 08.34 Uhr : Erstmals seit Jahren sind Rückenbeschwerden Ursache Nummer eins für Krankschreibungen. Wie Daten der KKH Kaufmännische Krankenkasse zeigen, sind im ersten Halbjahr 2021 bundesweit rund ein Fünftel (20,4 Prozent) der eingereichten Atteste auf Muskel-Skelett-Erkrankungen zurückzuführen...